Hans R. Figulla1*, MD; Katharina Kiss2, MD; Alexander Lauten3, MD
1. Kerckhoff Heart Center, Bad Nauheim, Germany; 2. Intern Kardiologische Angiologische Gruppenpraxis, Vienna, Austria; 3. Department of Cardiology, Charité-Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
Considering the incidence of tricuspid regurgitation (TR) and its implications on functional status and long-term survival, TR is currently undertreated. With the increasing adoption of catheter-based treatments of other type